Cardiac safety assessment is an important factor that all kinds of new drugs must be investigated before entering clinical trials. It is also one of
In recent years, the proportion of respiratory diseases gradually increased and the market prospects of inhalation administration are also growing by its virtue of the
SAPA-DC 2017 Annual Scientific Seminar came to an end in Rockville, Maryland, USA on April 1, 2017. During the meeting, Dr. Wang Jun, VP
Shanghai Medicilon Inc.